HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Hypophosphatemic osteomalacia acquired after renal transplantation: a a cause of severe osteoporosis].

Abstract
Renal osteodystrophy improves after renal transplantation but, after the procedure, other forms of bone disease emerge. We report a male patient that received a renal allograft four years before, who consulted for low back pain secondary to multiple vertebral compression fractures. The patient had good renal function, a parathormone independent hyperphosphaturia, normal 25-OH cholecalciferol, increased urinary hydroxyproline, decreased osteocalcin, reduced bone density and a bone biopsy revealing osteomalacia. The diagnosis of hypophosphatemic osteomalacia was reached and treatment with phosphates and ergocalciferol was started but, despite this, the patient suffered a new fracture two years later. Two mechanisms can produce hypophosphatemia after a renal transplantation: a parathormone excess due to the previous renal failure, that disappears during the first year after the transplantation or a derangement in renal phosphate transport that can be due to a generalized proximal tubule solute transport derangement (Fanconi syndrome), parathormone hypersensitivity or to an "idiopathic" hyperphosphaturia. Despite a good treatment, bone mass is not recovered and there is a high fracture risk. Mineral metabolism must be closely monitored after a renal allograft and its alterations must be quickly treated.
AuthorsF González, C Gómez, A Ayala, E Roessler
JournalRevista medica de Chile (Rev Med Chil) Vol. 123 Issue 1 Pg. 85-9 (Jan 1995) ISSN: 0034-9887 [Print] Chile
Vernacular TitleOsteomalacia hipofosfémica adquirida post-trasplante renal: una causa de osteoporosis grave.
PMID7569451 (Publication Type: Case Reports, English Abstract, Journal Article)
Chemical References
  • Ergocalciferols
  • Phosphates
Topics
  • Adult
  • Ergocalciferols (therapeutic use)
  • Humans
  • Kidney Transplantation (adverse effects)
  • Male
  • Osteomalacia (diagnosis, drug therapy, etiology)
  • Osteoporosis (diagnosis, drug therapy, etiology)
  • Phosphates (therapeutic use)
  • Severity of Illness Index

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: